Retraction
Involvement of miR-4262 in paclitaxel resistance through the regulation of PTEN in non-small cell lung cancer
Paper Information
Record ID:
48839
Author(s):
Journal:
Publication Date:
July 24, 2019
Retraction Date:
November 03, 2023
(2.0 years years ago)
Subjects:
Institutions:
- Department of Thoracic Surgery, First Affiliated Hospital of Kunming Medical University, Kunming, Yunnan 650032, People's Republic of China
- Clinical Medicine 2015, Second Clinical Medical College of Fujian Medical University, Quanzhou, Fujian 362000, People's Republic of China
- Department of Oncology Radiotherapy, First Affiliated Hospital of Kunming Medical University, Kunming, Yunnan 650032, People's Republic of China
Country:
🇨🇳 ChinaArticle Type:
Publisher:
Royal Society Publishing
Open Access:
Yes
DOI:
PubMed ID:
Retraction PubMed ID:
Retraction Details
Citations (30)
30
Total Citations1
Post-Retraction(3.3%)
29
Pre-Retraction0
Same DayPost-Retraction Citation Analysis
0
Within 30 days
1
Within 1 year
0
After 2+ years
316
Days since retraction (latest)
tRNA modifications and tRNA-derived small RNAs: new insights of tRNA in human disease
Di Wu, Xiuling Li, Faheem Ahmed Khan et al. (8 authors)
Cell Biology and Toxicology
Open Access
Published: Sep 2024
5 citations
5 citations
316 days after retraction
MiR-138-5p improves the chemosensitivity of MDA-MB-231 breast cancer cell line to paclitaxel
Mina Rasoolnezhad, Reza Safaralizadeh, Mohammad Ali Hosseinpour Feizi et al. (7 authors)
Molecular Biology Reports
Open Access
Published: Aug 2023
4 citations
4 citations
71 days before retraction
Role of microRNAs in regulation of doxorubicin and paclitaxel responses in lung tumor cells
Amirhosein Maharati, Meysam Moghbeli
Cell Division
Open Access
Published: Jul 2023
9 citations
9 citations
105 days before retraction
The role of selected non-coding RNAs in the biology of non-small cell lung cancer
Kajetan Kiełbowski, Konrad Ptaszyński, Janusz Wójcik et al. (4 authors)
Advances in Medical Sciences
Open Access
Published: Mar 2023
26 citations
26 citations
247 days before retraction
Hsa_circ_0092887 targeting <scp>miR</scp>‐490‐5p/<scp>UBE2T</scp> promotes paclitaxel resistance in non‐small cell lung cancer
Limei Wang, Zhiyong Zhang, Hui Tian
Journal of Clinical Laboratory Analysis
Open Access
Published: Dec 2022
11 citations
11 citations
316 days before retraction
miRNAs in anti-cancer drug resistance of non-small cell lung cancer: Recent advances and future potential
Hang Yan, Shengjie Tang, Shoujun Tang et al. (11 authors)
Frontiers in Pharmacology
Open Access
Published: Oct 2022
17 citations
17 citations
374 days before retraction
Resveratrol regulates <i>PINK1/Parkin</i>-mediated mitophagy via the lncRNA <i>ZFAS1-miR-150-5p-PINK1</i> axis, and enhances the antitumor activity of paclitaxel against non-small cell lung cancer
Fanhua Kong, Chuan Xie, Xudong Zhao et al. (8 authors)
Toxicology Research
Open Access
Published: Sep 2022
19 citations
19 citations
399 days before retraction
Relationship between the microRNAs and PI3K/AKT/mTOR axis: Focus on non-small cell lung cancer
Yi Lin, Linmin Zhang, Xifu Ding et al. (7 authors)
Pathology - Research and Practice
Published: Aug 2022
6 citations
6 citations
432 days before retraction
Hsa_circ_0011292 regulates paclitaxel resistance partially through regulating CDCA4 expression by serving as a miR-3619-5p sponge in non-small cell lung cancer
Yanan Bao, Yue Cui, Yumin Luan
Molecular & Cellular Toxicology
Published: Jul 2022
469 days before retraction
Paper citing Involvement of miR-4262 in paclitaxel resistance t...
Unknown Authors
Unknown Journal
Published: Jun 2022
494 days before retraction
Analysis of the lncRNA–miRNA–mRNA Network Reveals a Potential Regulatory Mechanism of EGFR-TKI Resistance in NSCLC
Dandan Ding, Jufeng Zhang, Zhiming Luo et al. (7 authors)
Frontiers in Genetics
Open Access
Published: Apr 2022
15 citations
15 citations
553 days before retraction
Noncoding RNAs and their therapeutics in paclitaxel chemotherapy: Mechanisms of initiation, progression, and drug sensitivity
Mahmood Khaksary Mahabady, Sepideh Mirzaei, Hamidreza Saebfar et al. (16 authors)
Journal of Cellular Physiology
Published: Apr 2022
21 citations
21 citations
564 days before retraction
Circ_0011292 knockdown mitigates progression and drug resistance in <scp>PTX</scp>‐resistant non‐small‐cell lung cancer cells by regulating <scp>miR</scp>‐433‐3p/<scp>CHEK1</scp> axis
Ming Jin, Fengping Zhang, Qiubo Li et al. (6 authors)
Thoracic Cancer
Open Access
Published: Mar 2022
14 citations
14 citations
584 days before retraction
Inhibition of Kelch-like epichlorohydrin-related protein 1 promotes the progression and drug resistance of lung adenocarcinoma
Hong Gao, Peipei Tang, Kejie Ni et al. (7 authors)
PeerJ
Open Access
Published: Aug 2021
806 days before retraction
PTEN Is Activated by the Addition of Cetuximab to Paclitaxel in Oral Squamous Cell Carcinoma
TOMOYUKI KII, Kaname Sakuma, Akira Tanaka
Anticancer Research
Open Access
Published: Jul 2021
4 citations
4 citations
855 days before retraction
Circ_0006948 Contributes to Cell Growth, Migration, Invasion and Epithelial–Mesenchymal Transition in Esophageal Carcinoma
Meng Yue, Yanxia Liu, Taiyang Zuo et al. (7 authors)
Digestive Diseases and Sciences
Published: Feb 2021
10 citations
10 citations
981 days before retraction
CRNDE Contributes Cervical Cancer Progression by Regulating miR-4262/ZEB1 Axis
Lu Ren, Shao-Qin Yang, Qinxue Cao et al. (4 authors)
OncoTargets and Therapy
Open Access
Published: Jan 2021
17 citations
17 citations
1036 days before retraction
Future epigenetic treatment strategies
Lingyue Gao, Lihui Wang
Elsevier eBooks
Published: Jan 2021
1036 days before retraction
Role of exosomal miRNAs in brain metastasis affected by radiotherapy
Zihuang Li, Hongli Yang, Ling Ye et al. (5 authors)
Translational Neuroscience
Open Access
Published: Jan 2021
8 citations
8 citations
1036 days before retraction
Long noncoding RNA FTX ameliorates hydrogen peroxide-induced cardiomyocyte injury by regulating the miR-150/KLF13 axis
Yamin Zhang, Xiaoying Fan, Hua Yang
Open Life Sciences
Open Access
Published: Dec 2020
12 citations
12 citations
1037 days before retraction
Role of non-coding RNAs in modulating the response of cancer cells to paclitaxel treatment
Soudeh Ghafouri‐Fard, Hamed Shoorei, Atefe Abak et al. (6 authors)
Biomedicine & Pharmacotherapy
Open Access
Published: Dec 2020
9 citations
9 citations
1044 days before retraction
Regulatory role of microRNAs on PTEN signaling
Soudeh Ghafouri‐Fard, Atefe Abak, Hamed Shoorei et al. (7 authors)
Biomedicine & Pharmacotherapy
Open Access
Published: Nov 2020
75 citations
75 citations
1091 days before retraction
Mechanisms of tRNA-derived fragments and tRNA halves in cancer treatment resistance
Yue Zhang, Huizhu Qian, Jing He et al. (4 authors)
Biomarker Research
Open Access
Published: Oct 2020
30 citations
30 citations
1114 days before retraction
Participation of MicroRNAs in the Treatment of Cancer with Phytochemicals
Seung Wan Son, Han Yeoung Lee, Sokviseth Moeng et al. (6 authors)
Molecules
Open Access
Published: Oct 2020
16 citations
16 citations
1115 days before retraction
Downregulated Mucin 1 alleviates paclitaxel resistance in non‑small cell lung cancer cells
Jin Xu, Hui Gao, Hua Li et al. (11 authors)
Molecular Medicine Reports
Open Access
Published: Jul 2020
4 citations
4 citations
1201 days before retraction
Mechanism underlying the significant role of the miR‑4262/SIRT1 axis in children with inflammatory bowel disease
Xiaozhi Deng, Lihong Shang, Min Du et al. (6 authors)
Experimental and Therapeutic Medicine
Open Access
Published: Jun 2020
5 citations
5 citations
1232 days before retraction
MiR-4262 inhibits the development of esophageal cancer by negatively regulating KLF6 level
Zhanye Liu, Chunlong Zhao, Shi-Xia Du et al. (5 authors)
Experimental and Molecular Pathology
Published: May 2020
5 citations
5 citations
1255 days before retraction
<p>MiR-153-5p Enhances the Sensitivity of Triple-Negative Breast Cancer Cells to Paclitaxel by Inducing G2M Phase Arrest</p>
Yang Wang, Nan Wu, Jun Zhang et al. (5 authors)
OncoTargets and Therapy
Open Access
Published: May 2020
21 citations
21 citations
1281 days before retraction
Targeting micro-RNAs by natural products: a novel future therapeutic strategy to combat cancer.
Abdullah M. Alnuqaydan
PubMed
Published: Jan 2020
19 citations
19 citations
1402 days before retraction
Abnormal increase of miR-4262 promotes cell proliferation and migration by targeting large tumor suppressor 1 in gliomas
Chunbo Liu, Tao Ma, Tianwei Jiang et al. (9 authors)
Pathology - Research and Practice
Published: Dec 2019
13 citations
13 citations
1432 days before retraction
Quick Stats
Total Citations:
30
Years Since Retraction:
2.0 years
Open Access:
Yes
Last Checked:
Jul 24, 2025